Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. CDC. Centers for Disease Control and Prevention. 2022 [cited 2022 Sep 5]. The biggest antibiotic-resistant threats in the U.S. Available from: https://www.cdc.gov/drugresistance/biggest-threats.html
2. Sekhri L, Kadri ML, Samira C, Senigra M. Synthesis of penicillin derivatives and study of their biological antibacterial activities. Biomed Pharm J. 2015;1:257–64.
3. Pan X, He Y, Chen T, Chan KF, Zhao Y. Modified Penicillin Molecule with Carbapenem-Like Stereochemistry Specifically Inhibits Class C β-Lactamases. Antimicrob Agents Chemother. 2017;61:e01288–17.
4. Zhu X, Liu D, Singh AK, Drolia R, Bai X, Tenguria S, et al. Tunicamycin Mediated Inhibition of Wall Teichoic Acid Affects Staphylococcus aureus and Listeria monocytogenes Cell Morphology, Biofilm Formation and Virulence. Front Microbiol. 2018;9:1352.
5. Huszár S, Singh V, Polčicová A, Baráth P, Barrio MB, Lagrange S, et al. N-Acetylglucosamine-1-Phosphate Transferase, WecA, as a Validated Drug Target in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2017;61:e01310–17.